E-LIB Suche - Ergebnisse für: Bruckner, Till

1

Regulatory gaps and research waste in clinical trials invol..:

Bruckner, Till ; Sanchez, Daniel ; Suljic, Tarik...
F1000Research. 13 (2024) - p. 431 , 2024

2

Are European clinical trial funders policies on clinical tr..:

O'Riordan, Marguerite ; Haslberger, Martin ; Cruz, Carolina...
Journal of Clinical and Translational Science. 7 (2023) 1 - p. , 2023

Link: https://doi.org/10.1017/..

3

Improving clinical trial transparency at UK universities: E..:

Mirjam Keestra, Sarai ; Rodgers, Florence ; Gepp, Sophie..
Clinical Trials. 19 (2022) 2 - p. 217-223 , 2022

Link: https://doi.org/10.1177/..

4

Results dissemination from completed clinical trials conduc..:

Riedel, Nico ; Wieschowski, Susanne ; Bruckner, Till...
Journal of Clinical Epidemiology. 144 (2022) - p. 1-7 , 2022

Link: https://doi.org/10.1016/..

5

Measurement challenges and causes of incomplete results rep..:

Bruckner, Till ; Wieschowski, Susanne ; Heider, Miriam...
PLOS ONE. 17 (2022) 8 - p. e0271976 , 2022

Link: https://doi.org/10.1371/..

6

Clinical trial reporting performance of thirty UK universit..:

Keestra, Sarai Mirjam ; Rodgers, Florence ; Lenz, Daphne...
Trials. 22 (2021) 1 - p. , 2021

Link: https://doi.org/10.1186/..

7

Deutsche Universitäten machen Ergebnisse klinischer Arzneim..:

Grabitz, Peter ; Brückner, Till ; Strech, Daniel
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 63 (2020) 12 - p. 1531-1537 , 2020

Link: https://doi.org/10.1007/..

8

Distancing design of phase III trials from drug company inf..:

Bruckner, Till
BMJ: British Medical Journal. 368 (2020) - p. 1 ff. , 2020

Link: https://www.jstor.org/st..

9

Navigating the Gray Zones of Third-Party Lobbying via Nonpr..:

, In: Lobbying in the European Union,

Bruckner, Till - p. 329-335 , 2018

Link: https://doi.org/10.1007/..

10

Improving clinical trial transparency at UK universities: E..:

Mirjam Keestra, Sarai ; Rodgers, Florence ; Gepp, Sophie..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036155/. , 2022

Link: http://www.ncbi.nlm.nih...

11

Measurement challenges and causes of incomplete results rep..:

Bruckner, Till ; Wieschowski, Susanne ; Heider, Miriam...
info:eu-repo/semantics/altIdentifier/issn/1932-6203. , 2022

Link: https://publications.rwt..

12

Results dissemination from completed clinical trials conduc..:

Riedel, Nico ; Wieschowski, Susanne ; Bruckner, Till...
https://freidok.uni-freiburg.de/data/223258. , 2022

Link: https://freidok.uni-frei..

13

Adoption of World Health Organization Best Practices in Cli..:

Bruckner, Till ; Rodgers, Florence ; Styrmisdóttir, Lea.
https://refubium.fu-berlin.de/handle/fub188/39103. , 2022

Link: https://refubium.fu-berl..

14

Dataset for the IntoValue 1 + 2 studies on results dissemin..:

Riedel, Nico ; Wieschowski, Susanne ; Bruckner, Till...
https://github.com/quest-bih/IntoValue2. , 2021

Link: https://zenodo.org/recor..

15

Clinical trial reporting performance of thirty UK universit..:

Keestra, Sarai Mirjam ; Rodgers, Florence ; Lenz, Daphne...
doi:10.17863/CAM.72315. , 2021

Link: https://doi.org/10.17863..